Nippon India Nifty Pharma ETF Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Nippon India Nifty Pharma ETF Growth Fund Overview

Min. investment

SIP ₹ & Lump. ₹1000

AUM (Fund size)

₹1,691 Cr

Lock In Period

N/A

Expense Ratio

N/A

Exit Load

Nil

Benchmark

Nifty Pharma Total Return

Nippon India Nifty Pharma ETF Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M1.65-0.7210.19
6M17.911.3833.00
1Y20.673.56111.63
3Y20.5411.53228.78

Portfolio Analysis

  • Equity: 99.78%
  • Debt: 0.22%
  • Others
As on: 2026-07-31
View allocation % by

1. Sun Pharmaceutical Industries Limited21.29%
2. Divi's Laboratories Limited10.34%
3. Cipla Limited8.37%
4. Torrent Pharmaceuticals Limited7.59%
5. Laurus Labs Limited7.14%
6. Dr. Reddy's Laboratories Limited7.07%
7. Lupin Limited5.93%
8. Aurobindo Pharma Limited4.42%
9. Alkem Laboratories Limited3.40%
10. Glenmark Pharmaceuticals Limited3.40%
11. Biocon Limited3.07%
12. Zydus Lifesciences Limited2.85%
13. Mankind Pharma Limited2.82%
14. IPCA Laboratories Limited2.45%
15. Gland Pharma Limited2.02%
16. Sai Life Sciences Limited1.83%
17. Wockhardt Limited1.63%
18. Ajanta Pharma Limited1.47%
19. Abbott India Limited1.46%
20. Piramal Pharma Limited1.23%
No Data Found
No Data Found

About Fund Nippon India Nifty Pharma ETF Growth

Nippon India Nifty Pharma ETF Growth managed by Nippon India Mutual Fund,is a Equity - Index Fundscheme with Assets Under Management of ₹1,691 Crore. The fund benchmarks its performance against the Nifty Pharma Total Return while maintaining an expense ratio of . Under the expert guidance of Jitendra Tolani ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Jitendra Tolani

Mr. Jitendra Tolani holds MBA (FINANCE). Prior to joining Nippon Mutual Fund, he was working with Motilal Oswal Financial Services Ltd, Asit C Mehta Investment Interrmediaries Ltd.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
ICICI Prudential Nifty Healthcare ETF Growth0235 CR0.15
ICICI Prudential BSE Midcap Select ETF Growth0112 CR0.16
Nippon India Nifty Pharma ETF Growth01,691 CR
Aditya Birla Sun Life Silver ETF Growth02,756 CR0.35
HDFC Silver ETF Growth07,472 CR0.5
Fund Name1Y3Y
This FundICICI Prudential Nifty Healthcare ETF Growth13.304574.6057
This FundICICI Prudential BSE Midcap Select ETF Growth13.43874.8883
This FundNippon India Nifty Pharma ETF Growth20.668875.1239
This FundAditya Birla Sun Life Silver ETF Growth111.4291227.4845
This FundHDFC Silver ETF Growth110.4029228.7771

Nippon India Nifty Pharma ETF Growth FAQs

Nippon India Nifty Pharma ETF Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Nippon India Nifty Pharma ETF Growth is . This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Nippon India Nifty Pharma ETF Growth’s fund performance is as follows:
  • 1 Month : 1.65%
  • 6 Months : 17.91%
  • 1 Year : 20.67%
  • 3 Years : 20.54%
Returns of Nippon India Nifty Pharma ETF Growth are updated daily based on NAV of ₹ 27.1675 as on Aug 20,2026. Since inception, the return has been 75.12%.

You can invest in Nippon India Nifty Pharma ETF Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Nippon India Nifty Pharma ETF Growth is ₹1,691 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Nippon India Nifty Pharma ETF Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.